Skip to content

Clinical trials

Atherosclerosis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Country / region: Australia Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20081
20093
20113
20123
20132
20141
20182
20191
20202
20211
20227
20231
20243
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting8
Active, not recruiting7
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
GlaxoSmithKline5
Amgen4
Boston Scientific Corporation3
Monash University3
AstraZeneca2
CSL Behring2
Novartis Pharmaceuticals2
480 Biomedical1
Abbott Medical Devices1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis42
Cardiovascular Diseases13
Peripheral Arterial Disease9
Coronary Artery Disease8
Acute Coronary Syndrome4
Coronary Disease4
Heart Diseases4
Hypercholesterolemia4
Hyperlipidemias4
Dyslipidemias3

Trials

Showing 26 to 42 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.